Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Feb;65(2):255–262. doi: 10.1038/bjc.1992.51

Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis.

D Forman 1, R T Oliver 1, A R Brett 1, S G Marsh 1, J H Moses 1, J G Bodmer 1, C E Chilvers 1, M C Pike 1
PMCID: PMC1977724  PMID: 1739626

Abstract

Forty-two families with two or more cases of testicular cancer have been reported to the UK Register for Familial Testicular Cancer, comprising two pairs of identical twins, 27 sets of other brothers (25 pairs, two triples), nine father-son pairs, two pairs of first cousins and two uncle-nephew pairs. In total 91 testicular tumours are described in 86 individuals (42 (46%) pure seminoma, 49 (54%) other germ cell tumours). The median age at diagnosis in these patients was significantly younger than that in a comparable series of non-familial patients (29 c.f. 32.5 years, P less than 0.01). In a case-control comparison of 794 testicular cancer patients, eight patients (1.0%) had a brother and four patients (0.5%) had a father with a previous diagnosis of testicular cancer at the time of their own diagnosis (and these families are all included in this report). Two out of 794 controls (0.3%) had a first degree relative with testicular cancer. The cumulative risk to a brother of a patient for developing testicular cancer by the age of 50 years was estimated to be 2.2% (95% C.I. 0.6-3.8%) which results in a relative risk of 9.8 (95% C.I. 2.8-16.7) in comparison with the general population. HLA Class I typing of 21 affected sib-pairs demonstrated four (19%) sharing two haplotypes, 13 pairs (62%) sharing one and four pairs (19%) sharing none. This did not differ significantly from the expected proportions of 25%/50%/25%. It is unlikely, therefore, that there is a major gene associated with testicular cancer predisposition within or closely linked to the major histocompatibility gene complex on chromosome 6.

Full text

PDF
255

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodmer J. G., Tonks S., Oza A. M., Lister T. A., Bodmer W. F. HLA-DP based resistance to Hodgkin's disease. Lancet. 1989 Jun 24;1(8652):1455–1456. doi: 10.1016/s0140-6736(89)90166-9. [DOI] [PubMed] [Google Scholar]
  2. DeWolf W. C., Lange P. H., Einarson M. E., Yunis E. J. HLA and testicular cancer. Nature. 1979 Jan 18;277(5693):216–217. doi: 10.1038/277216a0. [DOI] [PubMed] [Google Scholar]
  3. Dieckmann K. P., Becker T., Jonas D., Bauer H. W. Inheritance and testicular cancer. Arguments based on a report of 3 cases and a review of the literature. Oncology. 1987;44(6):367–377. doi: 10.1159/000226513. [DOI] [PubMed] [Google Scholar]
  4. Dieckmann K. P., Boeckmann W., Brosig W., Jonas D., Bauer H. W. Bilateral testicular germ cell tumors. Report of nine cases and review of the literature. Cancer. 1986 Mar 15;57(6):1254–1258. doi: 10.1002/1097-0142(19860315)57:6<1254::aid-cncr2820570632>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  5. Dieckmann K. P., von Keyserlingk H. J. HLA association of testicular seminoma. Klin Wochenschr. 1988 Apr 15;66(8):337–339. doi: 10.1007/BF01735790. [DOI] [PubMed] [Google Scholar]
  6. Dieckmann K. P., von Keyserlingk H. J. HLA typing in familial testicular cancer. Eur Urol. 1989;16(5):361–365. doi: 10.1159/000471617. [DOI] [PubMed] [Google Scholar]
  7. Easton D., Peto J. The contribution of inherited predisposition to cancer incidence. Cancer Surv. 1990;9(3):395–416. [PubMed] [Google Scholar]
  8. Gedde-Dahl T., Jr, Hannisdal E., Klepp O. H., Grøttum K. A., Waksvik H., Fosså S. D., Stenwig A. E., Brøogger A. Testicular neoplasms occurring in four brothers. A search for a genetic predisposition. Cancer. 1985 May 1;55(9):2005–2009. doi: 10.1002/1097-0142(19850501)55:9<2005::aid-cncr2820550930>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  9. Goss P. E., Bulbul M. A. Familial testicular cancer in five members of a cancer-prone kindred. Cancer. 1990 Nov 1;66(9):2044–2046. doi: 10.1002/1097-0142(19901101)66:9<2044::aid-cncr2820660933>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  10. Haseman J. K., Elston R. C. The investigation of linkage between a quantitative trait and a marker locus. Behav Genet. 1972 Mar;2(1):3–19. doi: 10.1007/BF01066731. [DOI] [PubMed] [Google Scholar]
  11. Hayakawa M., Mukai K., Nagakura K., Hata M. A case of simultaneous bilateral germ cell tumors arising from cryptorchid testes. J Urol. 1986 Aug;136(2):470–472. doi: 10.1016/s0022-5347(17)44913-5. [DOI] [PubMed] [Google Scholar]
  12. Kandel L. B., Heise E. R., Woodruff R. D., Harrison L. H., McCullough D. L., Dyer R. B. Testicular germ cell tumors in HLA-genotype non-twin brothers. Urology. 1988 Oct;32(4):315–319. doi: 10.1016/0090-4295(88)90233-6. [DOI] [PubMed] [Google Scholar]
  13. Knudson A. G., Jr Genetics of human cancer. Annu Rev Genet. 1986;20:231–251. doi: 10.1146/annurev.ge.20.120186.001311. [DOI] [PubMed] [Google Scholar]
  14. Kratzik C., Aiginger P., Kuzmits R., Spona J., Kirnbauer M., Seiser A., Mayr W. R. HLA-antigen distribution in seminoma, HCG-positive seminoma and non-seminomatous tumours of the testis. Urol Res. 1989;17(6):377–380. doi: 10.1007/BF00510530. [DOI] [PubMed] [Google Scholar]
  15. Lu S. J., Day N. E., Degos L., Lepage V., Wang P. C., Chan S. H., Simons M., McKnight B., Easton D., Zeng Y. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature. 1990 Aug 2;346(6283):470–471. doi: 10.1038/346470a0. [DOI] [PubMed] [Google Scholar]
  16. Májský A., Abrahámová J., Korínková P., Bek V. HLA system and testicular germinative tumours. Oncology. 1979;36(5):228–231. doi: 10.1159/000225347. [DOI] [PubMed] [Google Scholar]
  17. Oliver R. T. Atrophy, hormones, genes and viruses in aetiology germ cell tumours. Cancer Surv. 1990;9(2):263–286. [PubMed] [Google Scholar]
  18. Patel S. R., Kvols L. K., Richardson R. L. Familial testicular cancer: report of six cases and review of the literature. Mayo Clin Proc. 1990 Jun;65(6):804–808. doi: 10.1016/s0025-6196(12)62570-1. [DOI] [PubMed] [Google Scholar]
  19. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pollack M. S., Vugrin D., Hennessy W., Herr H. W., Dupont B., Whitmore W. F., Jr HLA antigens in patients with germ cell cancers of the testis. Cancer Res. 1982 Jun;42(6):2470–2473. [PubMed] [Google Scholar]
  21. Raghavan D., Jelihovsky T., Fox R. M. Father-son testicular malignancy. Does genetic anticipation occur? Cancer. 1980 Mar 1;45(5):1005–1009. doi: 10.1002/1097-0142(19800301)45:5<1005::aid-cncr2820450529>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  22. Savage M. O., Lowe D. G. Gonadal neoplasia and abnormal sexual differentiation. Clin Endocrinol (Oxf) 1990 Apr;32(4):519–533. doi: 10.1111/j.1365-2265.1990.tb00893.x. [DOI] [PubMed] [Google Scholar]
  23. Swerdlow A. J., Huttly S. R., Smith P. G. Testicular cancer and antecedent diseases. Br J Cancer. 1987 Jan;55(1):97–103. doi: 10.1038/bjc.1987.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tollerud D. J., Blattner W. A., Fraser M. C., Brown L. M., Pottern L., Shapiro E., Kirkemo A., Shawker T. H., Javadpour N., O'Connell K. Familial testicular cancer and urogenital developmental anomalies. Cancer. 1985 Apr 15;55(8):1849–1854. doi: 10.1002/1097-0142(19850415)55:8<1849::aid-cncr2820550834>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  25. Verp M. S., Simpson J. L. Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet. 1987 Apr;25(2):191–218. doi: 10.1016/0165-4608(87)90180-4. [DOI] [PubMed] [Google Scholar]
  26. Weissbach L., Widmann T. Familial tumor of the testis. Eur Urol. 1986;12(2):104–108. doi: 10.1159/000472592. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES